Alpha Tau Medical Ltd.(NASDAQ : DRTS)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.51%||64.80||1.0%||$543.24m|
|VRTX||Vertex Pharmaceuticals, Inc.||1.51%||273.73||1.9%||$497.98m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.37%||692.80||2.6%||$444.80m|
|SNSS||Sunesis Pharmaceuticals, Inc.||2.38%||2.15||0.7%||$150.29m|
|EXAS||EXACT Sciences Corp.||7.96%||53.83||17.7%||$134.25m|
|TXG||10X Genomics, Inc.||11.91%||52.99||0.0%||$106.79m|
|BMRN||BioMarin Pharmaceutical, Inc.||2.68%||80.97||4.2%||$95.42m|
|CRSP||CRISPR Therapeutics AG||5.63%||58.34||0.6%||$85.42m|
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company. It focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.